Physician

Andre J Witkin, M.D.

According to 2025 Medicare claims, Andre Witkin, M.D. (NPI: 1285811216) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Essex, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1437374428; TIN: 04-2500346) and primary practice location at 01923-3623. Witkin is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490) and Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Witkin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,128 traditional Medicare patients, billed 14,275 HCPCS/CPT codes, and received $2,373,181 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 440 prescription claims across 146 beneficiaries totaling $26,885 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $15,906. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,711 and ending at $26,885. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,219	8,307	$1,950,635
2016	1,264	10,241	$2,472,749
2017	1,252	10,828	$2,816,046
2018	1,159	11,828	$3,381,343
2019	1,218	12,935	$3,557,850
2020	1,024	10,047	$2,564,505
2021	1,169	11,430	$3,037,371
2022	1,201	12,474	$2,967,001
2023	1,218	15,624	$2,961,698
2024	1,128	14,275	$2,373,181

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	242	$19,711
2016	142	424	$26,654
2017	136	444	$33,994
2018	119	312	$31,084
2019	132	365	$33,176
2020	122	345	$28,327
2021	111	308	$17,528
2022	115	379	$22,961
2023	139	452	$37,512
2024	146	440	$26,885

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	428	508	$95
67028	Injection of drug into eye	343	1,497	$93
92014	Established patient complete exam of visual system	470	546	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	392	1,324	$69
92134	Imaging of retina	1,071	2,651	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	110	3,830	$4,007
Brimonidine Tartrate	Brimonidine Tartrate	30	1,600	$2,940
Ketorolac Tromethamine	Ketorolac Tromethamine	59	1,905	$732
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	42	3,400	$511
Latanoprost	Latanoprost	65	2,838	$378

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$2,940	Apellis Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$12,966	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andre J. Witkin, M.D.?

Tedicare shows public-source Medicare data for Andre J. Witkin, M.D. (NPI 1285811216), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andre J. Witkin, M.D. have ACO affiliation data?

Andre J. Witkin, M.D. is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490) and Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Andre J. Witkin, M.D.?

Andre J. Witkin, M.D. is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1437374428) in the available physician profile data.

Does Andre J. Witkin, M.D. have Open Payments data?

Andre J. Witkin, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.